cerrar
Tagged with Biotech

Interview: James Lennertz – Group VP and GM (EUMEA),…
James Lennertz, Group VP and GM EUMEA for BioMarin, discusses the key highlights of the past few years for BioMarin, their unique positioning as a…

Interview: Nic Alexakis – CEO, Swiss Biotech Association
The Swiss Biotech Association’s Nic Alexakis describes Switzerland’s thriving biotech scene and extensive support infrastructure, while also…

Why the J&J Takeover of Actelion Looks Unlikely
Johnson & Jonhson’s interest in taking over the Swiss biotech group Actelion has been confirmed, with the Wall Street Journal estimating that a…

Christophe Bourdon – SVP EMEA, Alexion Pharmaceuticals
Specializing in ultra-rare diseases, Alexion targets patient populations of less than 20 patients per million. Christophe Bourdon discusses…

Interview: Leonardo Torres – General Manager Mexico,…
Leonardo Torres, general manager Mexico, Central America & Caribbean of Shire, provides insights into the rapidly progressing integration of…

Mapping Swiss Pharma
It is tempting to characterize Switzerland’s global pharma and life science hotspots as beginning and ending with Basel – home of industry giants…

Interview: Dr. Andrea Michael Meyer – General Manager,…
Dr. Andrea Michael Meyer, general manager of Sanofi Genzyme Switzerland, reveals how the Swiss business has been experiencing year-on-year…

Interview: Darren Cunningham – Co-founder & CEO,…
Darren Cunningham tells us the story behind Inflection Biosciences (and its name), the rationale of focusing on small molecule cancer treatments,…

Interview: Dr. Carl Firth – CEO, ASLAN Pharmaceuticals,…
The CEO of ASLAN Pharmaceuticals, Dr. Carl Firth discusses the implications surrounding the company’s imminent initial public offering on Taiwan’s…

Interview: Elena Strapkova Boydova – Country Director,…
Biogen Slovakia's Country Director on being an innovative global biotech in Slovakia, market access in the country, and the company's commitment to…

Interview: Dr. Steven Fang – Executive Director,…
Biotech CRO InvitroCue Executive director Dr. Steven Fang explains how their technology has disrupted the current clinical trials landscape and the…

Interview: Natalia Perekhvatova – CEO, Mitotech, Luxembourg
The CEO of Mitotech introduces the ground-breaking nature of their products; why Mitotech chose Luxembourg to set up its headquarters, as well as the…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here